Literature DB >> 14993812

Expression and visualization of a human interferon-beta-enhanced green fluorescent protein chimeric molecule in cultured cells.

Masaru Nakamura1, Masato Maruyama, Fumiyoshi Yamashita, Yoshinobu Takakura, Mitsuru Hashida, Yoshihiko Watanabe.   

Abstract

We have constructed a recombinant cDNA encoding the chimeric protein between human IFN-beta (HuIFN-beta) and enhanced green fluorescent protein (EGFP) to elucidate the intracellular localization of IFN-beta. Transient expression of the chimeric molecule, HuIFN-beta-EGFP, in L cells demonstrated that the chimeric molecule secreted from the cells had an intact biological activity as far as antiviral effect was concerned. Immunostaining of the transfected cells using anti-HuIFN-beta antibody demonstrated that green-fluorescence was co-localized with the IFN signal and its profile was similar to IFN signals in the cells transfected with HuIFN-beta expressing plasmid DNA. These results indicate that the HuIFN-beta-EGFP chimeric gene was expressed as a chimeric protein and the chimera was transported via the regular secretory pathway in the cells. In other cell types, the fluorescence derived from the chimeric protein was also seen on cytoplasmic vesicular structures. These results suggest that HuIFN-beta-EGFP will be a useful tool to investigate the intracellular trafficking processes of HuIFN-beta in a variety of cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993812     DOI: 10.1248/bpb.27.411

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses.

Authors:  R T Trifonova; G F Doncel; R N Fichorova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

2.  Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means.

Authors:  Michael Puckette; J Barrera; M Schwarz; M Rasmussen
Journal:  BMC Biotechnol       Date:  2022-03-29       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.